XOLREMDI Trademark

Trademark Overview

On Wednesday, January 20, 2021, a trademark application was filed for XOLREMDI with the United States Patent and Trademark Office. The USPTO has given the XOLREMDI trademark a serial number of 90476808. The federal status of this trademark filing is REGISTERED as of Tuesday, August 27, 2024. This trademark is owned by X4 Pharmaceuticals, Inc.. The XOLREMDI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of WHIM syndrome; Pharmaceutical preparations for the treatment of immunodeficiencies; Pharmaceutical preparations for the treatment of neutropenia
xolremdi

General Information

Serial Number90476808
Word MarkXOLREMDI
Filing DateWednesday, January 20, 2021
Status700 - REGISTERED
Status DateTuesday, August 27, 2024
Registration Number7489281
Registration DateTuesday, August 27, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 7, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of WHIM syndrome; Pharmaceutical preparations for the treatment of immunodeficiencies; Pharmaceutical preparations for the treatment of neutropenia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 21, 2021
Primary Code005
First Use Anywhere DateTuesday, April 30, 2024
First Use In Commerce DateTuesday, April 30, 2024

Trademark Owner History

Party NameX4 Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02134
Party NameX4 Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02134
Party NameX4 Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02134

Trademark Events

Event DateEvent Description
Tuesday, August 3, 2021ASSIGNED TO EXAMINER
Saturday, January 23, 2021NEW APPLICATION ENTERED
Wednesday, April 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 18, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 7, 2021PUBLISHED FOR OPPOSITION
Tuesday, September 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 2, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 29, 2022SOU TEAS EXTENSION RECEIVED
Friday, April 29, 2022SOU EXTENSION 1 FILED
Friday, April 29, 2022SOU EXTENSION 1 GRANTED
Monday, October 31, 2022SOU EXTENSION 2 FILED
Monday, October 31, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 31, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 31, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 31, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 31, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 31, 2022SOU EXTENSION 2 GRANTED
Sunday, April 30, 2023SOU TEAS EXTENSION RECEIVED
Sunday, April 30, 2023SOU EXTENSION 3 FILED
Sunday, April 30, 2023SOU EXTENSION 3 GRANTED
Tuesday, May 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 30, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 30, 2024SOU EXTENSION 5 GRANTED
Tuesday, April 30, 2024SOU EXTENSION 5 FILED
Saturday, October 28, 2023SOU TEAS EXTENSION RECEIVED
Saturday, October 28, 2023SOU EXTENSION 4 FILED
Saturday, October 28, 2023SOU EXTENSION 4 GRANTED
Wednesday, May 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2024USE AMENDMENT FILED
Monday, June 3, 2024TEAS STATEMENT OF USE RECEIVED
Sunday, July 14, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 16, 2024STATEMENT OF USE PROCESSING COMPLETE
Saturday, July 20, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, July 20, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 27, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, October 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 27, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

xolremdi pharmaceutical treatment preparations neutropenia immunodeficiencies whim syndrome